10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: A community-based prospective cohort study

The Lancet Diabetes and Endocrinology

Volumn 4, Issue 1, 2016, Pages 27-34

  Ohn, Jung Hun ^a,b   Kwak, Soo Heon ^a   Cho, Young Min ^a   Lim, Soo ^a,b   Jang, Hak Chul ^a,b   Park, Kyong Soo ^a,c   Cho, Nam H ^d  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; DETERIORATION; DIABETOGENESIS; DISEASE COURSE; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 2; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LONGITUDINAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84955338292     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00336-8     Document Type: Article

References (30)

1. IDF Diabetes Atlas 2013, International Diabetes Federation, International Diabetes Federation, Brussels.
2. Weyer C, Bogardus C, Mott DM, Pratley RE The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999, 104:787-794.
3. Festa A, Williams K, D'Agostino R, Wagenknecht LE, Haffner SM The natural course of β-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 2006, 55:1114-1120.
4. Cnop M, Vidal J, Hull RL, et al. Progressive loss of β-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 2007, 30:677-682.
5. Lyssenko V, Almgren P, Anevski D, et al. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes 2005, 54:166-174.
6. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009, 373:2215-2221.
7. Morimoto A, Tatsumi Y, Deura K, et al. Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku study. Diabetologia 2013, 56:1671-1679.
8. Kahn SE The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003, 46:3-19.
9. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 2012, 44:981-990.
10. Mahajan A, Go MJ, Zhang W, et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 2014, 46:234-244.
11. Scott RA, Lagou V, Welch RP, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet 2012, 44:991-1005.
12. Vaxillaire M, Veslot J, Dina C, et al. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 2008, 57:244-254.
13. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009, 41:89-94.
14. Lyssenko V, Jonsson A, Almgren P, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008, 359:2220-2232.
15. Cho NH, Jang HC, Choi SH, et al. Abnormal liver function test predicts type 2 diabetes: a community-based prospective study. Diabetes Care 2007, 30:2566-2568.
16. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004, 27(suppl 1):S5-10.
17. Tura A, Kautzky-Willer A, Pacini G Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract 2006, 72:298-301.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
19. Matsuda M, DeFronzo RA Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
20. Kwak SH, Kim SH, Cho YM, et al. A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes 2012, 61:531-541.
21. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 2012, 44:955-959.
22. Youden WJ Index for rating diagnostic tests. Cancer 1950, 3:32-35.
23. Neter J, Kutner MH, Nachtsheim CJ, Wasserman W Applied linear statistical models 1996, McGraw-Hill/Irwin, Chicago.
24. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006, 368:1681-1688.
25. Ikehara S, Tabak AG, Akbaraly TN, et al. Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study. Diabetologia 2015, 58:534-542.
26. Jeon JY, Ha KH, Kim DJ New risk factors for obesity and diabetes: environmental chemicals. J Diabetes Investig 2015, 6:109-111.
27. Kutlu B, Burdick D, Baxter D, et al. Detailed transcriptome atlas of the pancreatic beta cell. BMC Med Genomics 2009, 2:3.
28. Ingelsson E, Langenberg C, Hivert MF, et al. Detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans. Diabetes 2010, 59:1266-1275.
29. Walford GA, Green T, Neale B, et al. Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism. Diabetologia 2012, 55:331-339.
30. Go MJ, Hwang JY, Park TJ, et al. Genome-wide association study identifies two novel loci with sex-specific effects for type 2 diabetes mellitus and glycemic traits in a Korean population. Diabetes Metab J 2014, 38:375-387.